This research explores how autoimmune disease affects identity in young adults. Interviews with 25 New Zealanders revealed that diagnosis reshapes identity, relationships with the body, and perceptions of disability. The findings suggest that supporting identity—not just treating disease—could improve health behaviours, wellbeing, and long-term outcomes for people with autoimmune conditions.

This research investigates whether weight loss from the GLP-1 drug semaglutide includes loss of muscle mass. Using an obesity mouse model and direct muscle measurements, the study found significant muscle loss in females but not males. The findings highlight important sex differences and the need to evaluate body composition, not just weight loss.